464 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by World Investment Advisors LLC

World Investment Advisors LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, Holdings Channel reports. The fund bought 464 shares of the medical equipment provider’s stock, valued at approximately $228,000.

Other institutional investors have also recently made changes to their positions in the company. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the 2nd quarter valued at $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. LGT Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the third quarter worth about $33,000. Finally, Mark Sheptoff Financial Planning LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at about $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $523.91 on Friday. The company has a market cap of $186.61 billion, a P/E ratio of 84.23, a P/E/G ratio of 5.35 and a beta of 1.38. The stock has a 50-day moving average of $526.05 and a two-hundred day moving average of $482.16. Intuitive Surgical, Inc. has a 1-year low of $320.26 and a 1-year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on ISRG. Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Piper Sandler reissued an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.